Identity
- Trade Name
- XXL DIVISYS EUDAMED
- Device Name
- XXL DIVISYS EUDAMED
- Model / Reference
- XXL EUDAMEDXB1P8D103 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 03664897013054 EUDAMED
- Basic UDI-DI
- 366489700503HA EUDAMED
- Direct Marketing DI
- 03664897013054 EUDAMED
- EMDN Code
- V08060101 HOSPITAL/HOME CARE ELECTRIC MEDICAL BEDS EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- France EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Basic electric hospital bed
Xxl Divisys by Winncare France — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Basic electric hospital bed.
- Electrical Hospital Bed — PARAMOUNT BED CO., LTD. · Class I
- 48 Advantage Bed — SIZEWISE RENTALS, L.L.C. · Class II
- MATRIX U24 — IMO - Indústrias Metalúrgicas, S.A. · Class I
- Electric Hospital Bed — HEBEI DANSONG MEDICAL EQUIPMENT CO.,LTD · Class I
- BED G RECOM PLUS L/TUBE 105X206 DARKGREY — TECNIMOEM CARE S.L. · Class I
- MC Healthcare — Span-America Medical Systems, Inc. · Class II
- Electric Bed — Jiangmen Jia Mei Medical Products Co.,Ltd. · Class I
- Electrical Hospital Bed — PARAMOUNT BED CO., LTD. · Class I
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 366489700503HA | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Winncare France
- EUDAMED SRN
- FR-MF-000000482
Sources (1)
- EUDAMED ad08c58d-5334-4a1d-9504-3bc88fa43831 61 fields · synced Aug 3, 2026